Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Trial Profile

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Jun 2017

At a glance

  • Drugs SPARC-1613 (Primary)
  • Indications Breast cancer
  • Focus Pharmacokinetics
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 24 May 2017 Planned initiation date changed from 15 May 2017 to 15 Jul 2017.
    • 19 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top